He is also an Distinguished Associated Professor of School of Biological Science and Medical Engineering at Beihang University (China). Dr. Zufeng Ding’s research concentrates on the molecular, cellular and physiological factors that are involved in lectin-like ox-LDL scavenger receptor-1 (LOX-1) mediated cardiovascular diseases, such as atherosclerosis, hypertension and myocardial ischemia. Current work focuses on the interaction between LOX-1 and proprotein convertase subtilisin/kexin type 9 (PCSK9). He was the first to identify that PCSK9 is expressed much lower in LOX-1 knockout mice compared with wild type mice, and both PCSK9 and LOX-1 are expressed to a greater extent in vascular smooth muscle cells than in endothelial cells. In the past 5 years, more than 50 peer-reviewed papers were published in Dr. Zufeng Ding’s Lab.